Us Bancorp »

Eliem Therapeutics shares owned by Us Bancorp

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Us Bancorp

Quarter filed Position value Share count Share price at filing
2024-09-30 $718 141 5.09

More positions owned by Us Bancorp

Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Msci Eafe (IEFA)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Core Msci Emkt (IEMG)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
NVIDIA Corporation (NVDA)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)

View all positions for Us Bancorp

Top funds holding Eliem Therapeutics

RA Capital Management
Samsara BioCapital
Boxer Capital
BlackRock
Affinity Asset Advisors
T. Rowe Price Associates
Geode Capital Management
Driehaus Capital Management
Point72 Asset Management
Nan Fung Group Holdings
Northern Trust
Dr. Jeffrey R. Jay, M.D.
Monashee Investment Management
Ikarian Capital
TD Asset Management

View all funds holding Eliem Therapeutics